Evidence map›Paper›PMID 39411226›Full record

ArticleOpen forum infectious diseases2024

Posttraumatic

Ali Qasim Mohammad Taher, Rasha Aqel, Mohammed Alnajjar, Caroline Walker, Ernestina Repetto, Marwah Raad, Fabiola Gordillo Gomez, Innocent Nyaruhirira, Justine Michel, Patrick Herard and 3 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ali Qasim Mohammad TaherMosul Project, Iraq Mission, Operational Centre Brussels, Médecins Sans Frontières, Mosul City, Iraq.
Rasha AqelLondon Health Science Centre, Western University, London, Ontario, Canada.
Mohammed AlnajjarGaza Mission, Operational Centre Brussels, Médecins Sans Frontières, Gaza, Palestine.
Caroline WalkerLuxembourg Operational Research Unit, Médecins Sans Frontières, Luxembourg City, Luxembourg.
Ernestina RepettoInfectious Diseases Services, Clinique Universitaire Saint Pierre, Brussels, Belgium.
Marwah RaadMosul Project, Iraq Mission, Operational Centre Brussels, Médecins Sans Frontières, Mosul City, Iraq.
Fabiola Gordillo GomezMedical Department, Operational Centre Brussels, Médecins Sans Frontières, Brussels, Belgium.
Innocent NyaruhiriraMedical Department, Operational Centre Brussels, Médecins Sans Frontières, Brussels, Belgium.
Justine MichelMedical Department, Operational Centre Paris, Médecins Sans Frontières, Paris, France.
Patrick HerardMedical Department, Operational Centre Paris, Médecins Sans Frontières, Paris, France.
Rupa KanapathipillaiMedical Department, Operational Centre Paris, Médecins Sans Frontières, Paris, France.
Krystel MoussallyLebanon Branch Office, Middle East Medical Unit, Operational Centre Brussels, Médecins sans Frontières, Beirut, Lebanon.ORCID https://orcid.org/0000-0002-1260-0690
Mohamad KhalifeMedical Department, Operational Centre Brussels, Médecins Sans Frontières, Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The history of conflicts in the Middle East has resulted in a high burden of complications from conflict-related wounds like posttraumatic osteomyelitis (PTO). This is particularly challenging to manage in settings like Mosul, Iraq and Gaza, Palestine, where healthcare systems are weakened. In nonconflict settings, PTO caused by Methods: We conducted a retrospective cohort study on patients with PAPTO diagnosed with culture of intraoperative bone biopsy, using routinely collected data. Results: Among 66 PAPTO episodes from 61 enrolled patients, 37.9% had a multidrug-resistant Conclusions: Management of PAPTO in the conflict-affected, low-resource settings of Mosul and Gaza achieved a recurrence rate aligned with global reports through appropriate and targeted antibiotic use, primarily in monotherapy, provided over a mean treatment duration of 45.5 days.

Indexed as

antibiotic resistanceGazaIraqposttraumatic osteomyelitisPseudomonas aeruginosa

Identifiers

PMID39411226
PMCPMC11475744

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.